Due to health issues, this site is no longer maintained and will be shut down shortly. |
argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:ARGX.
$359.46 -1.06 (-0.29%)
As of 03/27/2023 11:19:58 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.